Home News

2018 full year results presentation

Operating income, growth figures, profitability and how our products have behaved.

Tue, 26/02/2019 - 11:15 0 min
Download related document
No votes yet
 
Related
Full Year 2019 results presentation
0 min
26/02/2020
ROVI reports operating revenue growth of 26% and EBITDA growth of 106%
ROVI reports operating revenue growth of 26% and EBITDA growth of 106%
Operating revenue increased by 26% to 381.3 million euros in 2019, mainly driven by the strength of the specialty pharmaceutical...
6 min
26/02/2020
ROVI announces the commencement of the assessment process to obtain marketing authorisation for Doria® in the European Union
ROVI announces the commencement of the assessment process to obtain marketing...
ROVI filed its application for marketing authorisation for Doria® with the European health authorities, the European Medicines Agency (EMA...
2 min
31/01/2020